Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.550
-0.020 (-3.51%)
Dec 20, 2024, 4:00 PM EST

Elite Pharmaceuticals Company Description

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.

The company operates through Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals segments.

It owns, licenses, manufactures, and sells various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets, and 15mg and 30mg capsules for the treatment of bariatrics under Adipex-P brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia brand; and Isradipine 2.5mg and 5mg capsules for cardiovascular diseases.

In addition, the company provides Trimipramine Maleate Immediate Release antidepressant capsules under the Surmontil brand; Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Immediate Release tablets under the Adderall brand, as well as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended Release capsules under the Adderall XR brand for central nervous system diseases; Dantrolene Sodium capsules for muscle relaxant under the Dantrium brand; SequestOX, an immediate release Oxycodone with Naltrexone; Loxapine Succinate capsules for treating antipsychotic under the Loxapine brand; Acetaminophen and Codeine Phosphate for the management of mild to moderate pain; and antibiotic products.

Further, it manufactures controlled-release products on a contract basis for third parties in the areas of pain, allergy, bariatric, attention deficit, and infection.

Additionally, the company is developing a range of abuse deterrent opioid products. Elite Pharmaceuticals, Inc. was incorporated in 1997 and is headquartered in Northvale, New Jersey.

Elite Pharmaceuticals, Inc.
Country United States
Founded 1997
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 64
CEO Nasrat Hakim

Contact Details

Address:
165 Ludlow Avenue
Northvale, Nevada 07647
United States
Phone 201 750 2646
Website elitepharma.com

Stock Details

Ticker Symbol ELTP
Exchange OTCMKTS
Fiscal Year April - March
Reporting Currency USD
ISIN Number US28659T2006
SIC Code 2834

Key Executives

Name Position
Nasrat Hakim Chairman, Chief Executive Officer and President
Carter J. Ward CPA, CSCP Chief Financial Officer
Douglas Plassche Executive Vice President of Operations
Dianne Will Vice President of Investor Relations and Corporate Affairs
Dr. George Kenneth Smith J.D., M.B.A., Ph.D. Vice President of Legal
Kirko Kirkov Chief Commercial Officer